Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Jan 09, 2006	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	22	$17.60	65,926
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.60	64,749
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.53	64,681
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.48	64,664
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.47	64,647
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.34	64,579
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.24	63,596
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.23	63,579
Jan 09, 2004	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	17	$15.18	63,528
Jan 09, 2006	YANCOPOULOS GEORGE Director, EVP, CSO, & Pres Regn Res Labs	Director, EVP, CSO, & Pres Regn Res Labs	Form 4	Open market or private sale of non-derivative or derivative security	16	$17.52	66,412

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media